Scott Romine - Dec 14, 2023 Form 4 Insider Report for Jackson Financial Inc. (JXN)

Signature
/s/ Kristan L. Richardson, as Attorney-in-Fact
Stock symbol
JXN
Transactions as of
Dec 14, 2023
Transactions value $
-$254,850
Form type
4
Date filed
12/18/2023, 04:36 PM
Previous filing
Dec 1, 2023
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JXN Common Stock Award $0 +47.2 +0.07% $0.00 72K Dec 14, 2023 Direct F1
transaction JXN Common Stock Award $0 +73.3 +0.1% $0.00 72.1K Dec 14, 2023 Direct F2
transaction JXN Common Stock Award $0 +147 +0.2% $0.00 72.2K Dec 14, 2023 Direct F3
transaction JXN Common Stock Award $0 +195 +0.27% $0.00 72.4K Dec 14, 2023 Direct F4, F7
transaction JXN Common Stock Sale -$255K -5K -6.9% $50.97 67.4K Dec 14, 2023 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as part of the October 2021 Annual Grant. These RSUs vest over 30 months in three installments. The first third vested on the one-year anniversary of the grant date, October 4, 2022, the next third vested on the two-year anniversary of the grant date, October 4, 2023, and the remaining third vests on April 4, 2024. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
F2 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient on December 27, 2021 which reflected an adjustment to Mr. Romine's October 2021 Annual Grant, in connection with his promotion. These RSUs vest over 30 months in three equal installments. The first third vested on the one-year anniversary of the grant date, December 27, 2022, the next third vests on the two-year anniversary of the grant date, December 27, 2023, and the remaining third vests on June 27, 2024. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
F3 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as part of the March 2022 Annual Grant. These RSUs vest over three years. The first third vested on the one-year anniversary of the grant date, March 10, 2023, the next third vests on the two-year anniversary of the grant date, March 10, 2024, and the remaining third vests on the three-year anniversary of the grant date, March 10, 2025. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
F4 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as part of the March 2023 Annual Grant. These RSUs vest over three years, where the first third vests on the one-year anniversary of the grant date, March 10, 2024, the next third vests on the two-year anniversary of the grant date, March 10, 2025, and the remaining third vests on the three-year anniversary of the grant date, March 10, 2026. Upon vesting, full shares are distributed and fractional shares are applied to shares withheld to cover tax obligations.
F5 The sale of shares occurred pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023. This transaction is the final order under Mr. Romine's 10b5-1 Plan.
F6 Shares were sold in multiple transactions, each transaction at $50.97. The reporting person undertakes to provide, upon request by Jackson Financial Inc., any security holder of Jackson Financial Inc., or the staff of the U.S. Securities and Exchange Commission, full information regarding the number of shares sold at the price set forth in this footnote.
F7 The total reflects adjustments to correct inadvertent errors in the number of shares awarded in the March 10, 2023, equity grant, and subsequent accruals of dividend equivalent units in March, June, and September, the number of RSUs that vested on an accelerated basis on November 29, 2023, and the number of shares withheld on that date.

Remarks:

Power of Attorney on file.